Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Micturition Reflex01:26

The Micturition Reflex

Urination, or micturition involves the coordination of the bladder's detrusor muscle and two sphincters to ensure controlled bladder emptying.
The process begins with bladder filling, where the bladder wall stretches as urine accumulates. This stretching activates the urine storage reflex, mediated by the sacral spinal segments and the pontine storage center. Efferent sympathetic impulses stimulate the detrusor muscle to relax and the internal urethral sphincter to contract, facilitating urine...
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Urinary Bladder01:23

Urinary Bladder

The urinary bladder is a hollow, muscular sac that temporarily stores urine before it is expelled from the body. It can hold approximately 600 mL of urine prior to micturition. The bladder is retroperitoneal and located behind the pubic symphysis in the pelvic floor.
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
Irritable Bowel Syndrome01:23

Irritable Bowel Syndrome

DefinitionIrritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent combinations of abdominal pain, bloating, diarrhea, or constipation.Pathophysiology of irritable bowel syndromeIts pathophysiology is multifactorial, involving disturbances in motility, sensory processing, microbial balance, barrier integrity, and gut–brain communication. These mechanisms interact to produce symptoms that vary across IBS subtypes.Altered Motility PatternsDisordered...
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quality of life in patients undergoing surgical correction of the exstrophy-epispadias complex in childhood.

World journal of urology·2026
Same author

DART-VAG: initial clinical experience with a novel autologous technique for penile girth augmentation.

World journal of urology·2026
Same author

Gender dysphoria in congenital adrenal hyperplasia: A review of the cases described in the literature.

Journal of pediatric urology·2026
Same author

Psychological and Psychiatric Issues in Functional Constipation, Fecal Incontinence and Bladder and Bowel Dysfunction-A Revised and Updated Document of the International Children's Continence Society (ICCS).

Neurourology and urodynamics·2026
Same author

Parental Experiences With Nocturnal Enuresis: Treatment Use, Dissatisfaction, and Psychosocial Impact in a Large Metropolitan Pediatric Urology Practice.

Neurourology and urodynamics·2026
Same author

Clitoroplasty with corporoplasty in feminizing genitoplasty: Multicenter evaluation of sensory and cosmetic outcomes.

Journal of pediatric urology·2026
Same journal

Letter to the Editor re: "Opioid prescribing patterns and the effect of chronic kidney disease in pediatric urology population: A retrospective cohort analysis".

Journal of pediatric urology·2026
Same journal

A child and young person focused systematic review of scrotal ultrasound with Mitigants to identify missed torsion.

Journal of pediatric urology·2026
Same journal

Response to Letter to the Editor re: "ChatGPT-4o's performance on pediatric Vesicoureteral reflux".

Journal of pediatric urology·2026
Same journal

Commentary to "Preoperative intramuscular testosterone and urethrocutaneous fistula formation after primary hypospadias repair".

Journal of pediatric urology·2026
Same journal

Journal of Pediatric Urology Editorial Board policy statement on appropriate endpoints when conducting research on hydronephrosis/urinary tract dilation (UTD)/ureteropelvic junction obstruction (UPJO).

Journal of pediatric urology·2026
Same journal

Vesicoureteral reflux and anorectal malformations.

Journal of pediatric urology·2026
See all related articles

Related Experiment Video

Updated: May 13, 2026

Detrusor Underactivity Model in Rats by Conus Medullaris Transection
03:26

Detrusor Underactivity Model in Rats by Conus Medullaris Transection

Published on: August 28, 2020

Constipation in children with isolated overactive bladders.

Maria Luiza Veiga1, Patrícia Lordêlo, Tiago Farias

  • 1CEDIMI, (Center for Childhood Urinary Disorders), Department of Urology and Physiotherapy, Bahiana School of Medicine, Bahia, Brazil.

Journal of Pediatric Urology
|March 7, 2013
PubMed
Summary
This summary is machine-generated.

Children with isolated overactive bladder (IOAB) are significantly more likely to experience constipation than their peers without urinary symptoms. This study highlights a key link between bladder dysfunction and bowel issues in pediatric patients.

Keywords:
ChildConstipationIsolated overactive bladderPrevalence

Related Experiment Videos

Last Updated: May 13, 2026

Detrusor Underactivity Model in Rats by Conus Medullaris Transection
03:26

Detrusor Underactivity Model in Rats by Conus Medullaris Transection

Published on: August 28, 2020

Area of Science:

  • Pediatric Urology
  • Pediatric Gastroenterology
  • Child Health

Background:

  • Overactive bladder (OAB) is a common condition in children.
  • Constipation is a frequent comorbidity in pediatric urology patients.
  • The relationship between isolated overactive bladder (IOAB) and constipation requires further investigation.

Purpose of the Study:

  • To determine the prevalence of constipation in children diagnosed with isolated overactive bladder (IOAB).
  • To compare constipation rates in children with IOAB versus a control group without urinary complaints.

Main Methods:

  • A cross-sectional study involving 51 children with IOAB and 74 controls aged 4-14 years.
  • Constipation was assessed using the Rome III criteria via questionnaires.
  • IOAB was defined by urgency, frequency, or daytime incontinence without post-void residual urine.

Main Results:

  • Children with IOAB exhibited a significantly higher prevalence of constipation (54.9%) compared to controls (29.7%).
  • Specific Rome III criteria for constipation, including stool retention and hard stools, were more common in the IOAB group.
  • Constipation was more prevalent in males within the IOAB cohort.

Conclusions:

  • Children with IOAB have a substantially increased risk of constipation compared to children without urinary symptoms.
  • This study underscores the importance of evaluating bowel function in pediatric patients with IOAB.
  • Early identification and management of constipation may be crucial for children with IOAB.